# Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-08 20:29 UTC · Category: Business · Sources: 6 · Current Velocity: 4.29

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Investor's Business Daily | The 'Blowout' And 'Bull Case' News That Sent Two Biotechs Flying | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxQUzV0UTNwTEw2MFV0WlBBZ1ZsdkluZmYzdFBVc25yRzhQZzkzVDhTMTNqMlNpV2xuU1U1aG40cGlOVnlidHFhS0tXNXVMOGtDdWg0cmxHZVJJSlNZa2Z3cklWM09xMnMtdWFDWGJROU43TDFPZTRWcHZuQzdQMXgzOG9mVUhvamlXdW43SzVOdUFtNTVWLU9QUWJxZw?oc=5) |
| Yahoo Finance | These 2 Biotech Stocks Hit Record Highs Today | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxOdlc5YTE1c2VhRVhEd3VrelpxVFpHNUVqTGxPT213cXBERkx2aDgyckJOMWMtdGZLT0ZZVXBfS243dWRBSVRaSkVuWWJZeVNUWXBxVXFDTDBVV2VTYlhObjk4dXFQZDVmVlVIN1h1QlhlbUFTdFJCLVVNNlEzblZ6d2JlelpPdVdnWnlPcjlKUU1Ydw?oc=5) |
| Barron's | Roivant Sciences Stock Soars as Experimental Inhaled Drug Hits Mid-Stage Trial Goals | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxPbzl1dWdGVGdQVE1yTmFkbkR4ZGM0QXZjTjd1MjZ6aGVTTGZjNXI1ckg5Z3VHSjFhWHd5TmVuNTNyZGR4UDZTWVFMb2NhRFJ5RXBxYTJDSWRoNjNBRWdOc0F6NjNFQnVERWdjMWN6R1NFZkVzUERieHk1MlhQMmtfY0VHenBzbmFCbGc?oc=5) |
| Yahoo Finance | Roivant Stock Surges on 'Robust' Data from Rare Lung Disease Candidate | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxPU2RQdkJQWllBSVdOc0htX3YzMzg3Mk5SS3d1bVJ2S0xkSndzRXJTSlFvX0h2MHBjQndIWGJxRTBTOWZvNFU3VkVQeXJ1ckMwdXlGdU5HeDJQU1Y0ejFWeU03UHBZbjV4eEluLTlTVEtfNEE4SFhrYUl5TXQ2WDR5dDA3Ul9oSk92c2NDSUpjX0h6X3dSR1diSg?oc=5) |
| STAT | Roivant lung disease drug hits mid-stage study goals | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxNRV9QdU9Jbl94Z2lUMnRJRk4tTWZMS3RlRkRPdDRDbGphMTB2LXlyejBHSG16bVdyTE96SzljdmF6N0lfV2RKY1NyN25PMi1nSkFVQXVqVF9OdEtRRlVER0Z0amhuSnRsbWpYQ2R0enBOMEtZUzQ0MmtZWkdZOVlqOElGREhwNURDU0IzQXZRQUxkTFR1QW95TzF4WFZsZ3FpVmVYVmZlLTJkSmxzUU1ITF9tVQ?oc=5) |
| Reuters | Roivant's experimental lung disease drug meets goals in mid-stage study | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMi1gFBVV95cUxObVVOVGtSaDFaaGlUa2VydUZfZGlsTVhJZG1CRFZuVEM3Tnk1V2xhRHRCR3UtdkJzNTZQRXU4d3p6Yk9WNGpMZ09LVmtnNHJ1Qno4ZDhPMUhST2IxbW1vSkd2TWdTemRNS3ZITDU4c2NPVE95Uk5VdEFDN241NUkzQnpLZnB0TzhDSUNGdEFwQkYxZ1hDTm5zR0NqMjdsQkF6R0lCMnFRb0dVcjU1X1doTUFnME5jS2JOYXNpQkNZYmlRQ1NBUXc0WVU3bVRoRTF0RVpma2VR?oc=5) |
| Fierce Biotech | Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win | 2026-09-08 10:00 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxNUUtIa01NTDdkLUIzcWV1eTE2Nmg3azdkT050U0tEQkJPR3pKcUtfTFI0bDhnLU5WOFJDM3c4cTJMb2lKaDFFejI5eUp6SmEzWWFWUTR0SUt2WkpNd2Fyd3U0SEJadUZHeDhWaUgxZ1E4UjFCeEpnOHdjLTczMUowTUM1VC14QVBNNHJ3bFIxcUFOQWEwVlRVM013VDc5N0pDWnNyWUtB?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-08/roivant-s-14m-bet-on-bayer-s-inhaled-hypertension-med-pays-off-with-phase-2-win*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*